
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/">
  <dc:language>eng</dc:language>
  <dc:creator id="https://orcid.org/0000-0002-9887-4237">Ignjatović, Valentina</dc:creator>
  <dc:creator id="https://orcid.org/0000-0002-2589-3306">Janković Miljuš, Jelena</dc:creator>
  <dc:creator id="https://orcid.org/0000-0003-3656-6420">Rončević, Jelena</dc:creator>
  <dc:creator>Tatić, Svetislav</dc:creator>
  <dc:creator id="https://orcid.org/0000-0001-8475-2266">Išić Denčić, Tijana</dc:creator>
  <dc:creator id="https://orcid.org/0000-0001-5322-4559">Đorić, Ilona</dc:creator>
  <dc:creator id="https://orcid.org/0000-0002-2898-6671">Šelemetjev, Sonja</dc:creator>
  <dc:type>info:eu-repo/semantics/article</dc:type>
  <dc:identifier>https://phaidrabg.bg.ac.rs/o:25317</dc:identifier>
  <dc:identifier>doi:10.1007/s00418-021-02056-y</dc:identifier>
  <dc:description xml:lang="eng">ABSTRACT
Papillary thyroid carcinoma (PTC), a common endocrine malignancy, presents a challenge from a prognostic standpoint. Molecular alterations underlying PTC progression include deregulation of focal adhesion kinase (FAK) at post-transcriptional and post-translational levels. Searching for candidate markers of PTC progression, we investigated the prognostic significance of FAK alterations on mRNA/protein level. The expression levels and subcellular localisation of auto-phosphorylated FAK (pY397-FAK) were determined by western blot (WB) and immunohistochemistry. The quantity of total FAK mRNA, alternatively spliced FAK-Del26 and FAK-Del33 variants were analysed by RT-qPCR and related to pY397-FAK expression and subcellular distribution. The results were correlated with clinicopathological parameters of the patients. The expression of pY397-FAK was significantly elevated in malignant samples. Active FAK showed predominant cytoplasmic distribution with co-occurrence along the membrane, while nuclear staining was found less frequently. Expression of pY397-FAK in separate cellular compartments correlated with adverse clinicopathological parameters, but the strongest association was found when their mean scores were calculated. Alternatively spliced FAK-Del33 and total FAK transcripts positively correlated to pY397-FAK protein levels as well as to characteristics of PTC advancement. Over-expression of FAK on mRNA (total and Del-33) and activated protein (pY397-FAK) levels is a feature of PTC advanced stages. Of the analysed alterations, the mean pY397-FAK IHC score showed the best predictive performance. Correlation between mRNA FAK-Del33 and pY397-FAK expression implies a regulatory role of alternative splicing in PTC patients.</dc:description>
  <dc:description xml:lang="srp">Sažetak</dc:description>
  <dc:title xml:lang="eng">Focal adhesion kinase splicing and protein activation in papillary thyroid carcinoma progression</dc:title>
  <dc:publisher>Springer</dc:publisher>
  <dc:format>application/pdf</dc:format>
  <dc:format>6831 bytes</dc:format>
  <dc:rights>All rights reserved</dc:rights>
  <dc:subject xml:lang="eng">alternative splicing, focal adhesion kinase, papillary thyroid carcinoma, tumour prognostic factors, pY397-FAK</dc:subject>
  <dc:source>Histochemistry and cell biology 157(2)</dc:source>
  <dc:date>2021</dc:date>
</oai_dc:dc>
